{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:29:11Z","timestamp":1787689751575,"version":"build-2784847793"},"reference-count":53,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"am","delay-in-days":318,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["75N93022C00035"],"award-info":[{"award-number":["75N93022C00035"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19-AI181960"],"award-info":[{"award-number":["U19-AI181960"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI143673"],"award-info":[{"award-number":["R01AI143673"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32-GM149364"],"award-info":[{"award-number":["T32-GM149364"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.vaccine.2024.126405","type":"journal-article","created":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T02:56:35Z","timestamp":1729047395000},"page":"126405","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Chikungunya virus E2 B domain nanoparticle immunogen elicits homotypic neutralizing antibody in mice"],"prefix":"10.1016","volume":"42","author":[{"given":"Karen","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica M.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Basore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daved H.","family":"Fremont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126405_bb0005","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3389\/fmicb.2016.00959","article-title":"Neurological sequelae resulting from encephalitic alphavirus infection","volume":"7","author":"Ronca","year":"2016","journal-title":"Front Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126405_bb0010","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.3201\/eid1210.060529","article-title":"Chikungunya outbreaks caused by African genotype","volume":"12","author":"Yergolkar","year":"2006","journal-title":"India Emerging Infectious Diseases"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126405_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16516-x","article-title":"Reconstructing Mayaro virus circulation in French Guiana shows frequent spillovers","volume":"11","author":"Hoz\u00e9","year":"2020","journal-title":"Nature Communications"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126405_bb0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tim.2014.09.005","article-title":"Arthritogenic alphaviruses: new insights into arthritis and bone pathology","volume":"23","author":"Chen","year":"2015","journal-title":"Trends Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126405_bb0025","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/nrrheum.2012.64","article-title":"Arthritogenic alphaviruses\u2014an overview","volume":"8","author":"Suhrbier","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.vaccine.2024.126405_bb0030","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ijid.2021.03.003","article-title":"Risk of chronic arthralgia and impact of pain on daily activities in a cohort of patients with chikungunya virus infection from Brazil","volume":"105","author":"Silva","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126405_bb0035","article-title":"Chikungunya: its history in Africa and Asia and its spread to new regions in 2013\u20132014","volume":"214(suppl_5):S436-S40","author":"Zeller","year":"2016","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126405_bb0040","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3201\/eid1403.070720","article-title":"Increased mortality rate associated with chikungunya epidemic, Ahmedabad","volume":"14","author":"Mavalankar","year":"2008","journal-title":"India Emerging Infectious Diseases"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126405_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030263","article-title":"Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak","volume":"3","author":"Schuffenecker","year":"2006","journal-title":"PLoS Med"},{"issue":"12","key":"10.1016\/j.vaccine.2024.126405_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.0030201","article-title":"A single mutation in chikungunya virus affects vector specificity and epidemic potential","volume":"3","author":"Tsetsarkin","year":"2007","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126405_bb0055","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3390\/v14050969","article-title":"A review on chikungunya virus epidemiology, pathogenesis and current vaccine development","volume":"14","author":"De Lima Cavalcanti","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.vaccine.2024.126405_bb0060","first-page":"30","article-title":"Chikungunya: a decade of burden in the Americas","author":"de Souza","year":"2024","journal-title":"The lancet regional health \u2013 Americas"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126405_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41426-018-0163-5","article-title":"Mayaro: an emerging viral threat?","volume":"7","author":"Acosta-Ampudia","year":"2018","journal-title":"Emerging Microbes & Infections"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126405_bb0070","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.3201\/eid2211.161015","article-title":"Mayaro virus in child with acute febrile illness, Haiti, 2015","volume":"22","author":"Lednicky","year":"2016","journal-title":"Emerg Infect Dis"},{"issue":"18","key":"10.1016\/j.vaccine.2024.126405_bb0075","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.18.19563-en","article-title":"Infection with Mayaro virus in a French traveller returning from the Amazon region, Brazil, January, 2010","volume":"15","author":"Receveur","year":"2010","journal-title":"Eurosurveillance"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126405_bb0080","first-page":"343","article-title":"Imported Mayaro virus infection in the Netherlands","volume":"61","author":"Hassing","year":"2010","journal-title":"J Inf Secur"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126405_bb0085","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.3201\/eid2007.140043","article-title":"Genome analysis of Mayaro virus imported to Germany from French Guiana","volume":"20","author":"Friedrich-J\u00e4nicke","year":"2014","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126405_bb0090","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4269\/ajtmh.2011.11-0359","article-title":"Experimental transmission of Mayaro virus by Aedes aegypti","volume":"85","author":"Long","year":"2011","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126405_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007518","article-title":"Vector competence of Aedes aegypti, Aedes albopictus, and Culex quinquefasciatus mosquitoes for Mayaro virus","volume":"14","author":"Pereira","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2024.126405_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006895","article-title":"Anopheles mosquitoes may drive invasion and transmission of Mayaro virus across geographically diverse regions","volume":"12","author":"Brustolin","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"10394","key":"10.1016\/j.vaccine.2024.126405_bb0105","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(23)00641-4","article-title":"Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"401","author":"Schneider","year":"2023","journal-title":"Lancet"},{"issue":"7706","key":"10.1016\/j.vaccine.2024.126405_bb0110","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/s41586-018-0121-3","article-title":"Mxra8 is a receptor for multiple arthritogenic alphaviruses","volume":"557","author":"Zhang","year":"2018","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126405_bb0115","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2217\/fmb.09.59","article-title":"A structural and functional perspective of alphavirus replication and assembly","volume":"4","author":"Jose","year":"2009","journal-title":"Future Microbiol"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126405_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2019.04.006","article-title":"Cryo-EM structure of chikungunya virus in complex with the Mxra8 receptor","volume":"177","author":"Basore","year":"2019","journal-title":"Cell"},{"issue":"7324","key":"10.1016\/j.vaccine.2024.126405_bb0125","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.vaccine.2024.126405_bb0130","doi-asserted-by":"crossref","first-page":"10255","DOI":"10.1128\/JVI.01507-13","article-title":"The role of E3 in pH protection during alphavirus assembly and exit","volume":"87","author":"Uchime","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2024.126405_bb0135","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jcv.2019.06.001","article-title":"Characterization of antibody response in patients with acute and chronic chikungunya virus disease","volume":"117","author":"Anfasa","year":"2019","journal-title":"J Clin Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126405_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0011154","article-title":"Infection with chikungunya virus confers heterotypic cross-neutralizing antibodies and memory B-cells against other arthritogenic alphaviruses predominantly through the B domain of the E2 glycoprotein","volume":"17","author":"Powers","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"issue":"37","key":"10.1016\/j.vaccine.2024.126405_bb0145","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100104118","article-title":"Near-germline human monoclonal antibodies neutralize and protect against multiple arthritogenic alphaviruses","volume":"118","author":"Malonis","year":"2021","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126405_bb0150","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.chom.2020.07.008","article-title":"Human mAbs broadly protect against Arthritogenic alphaviruses by recognizing conserved elements of the Mxra8 receptor-binding site","volume":"28","author":"Powell","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126405_bb0155","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.cell.2015.10.050","article-title":"Broadly neutralizing alphavirus antibodies bind an epitope on E2 and inhibit entry and egress","volume":"163","author":"Fox","year":"2015","journal-title":"Cell"},{"issue":"696","key":"10.1016\/j.vaccine.2024.126405_bb0160","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ade8273","article-title":"A chikungunya virus\u2013like particle vaccine induces broadly neutralizing and protective antibodies against alphaviruses in humans","volume":"15","author":"Raju","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2024.126405_bb0165","article-title":"Protein-based antigen presentation platforms for nanoparticle vaccines","volume":"6(1):70","author":"Nguyen","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2024.126405_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2020.01.007","article-title":"Shaping humoral immunity to vaccines through antigen-displaying nanoparticles","volume":"65","author":"Irvine","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2024.126405_bb0175","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.csbj.2015.11.001","article-title":"Self-assembling protein nanoparticles in the design of vaccines","volume":"14","author":"L\u00f3pez-Sagaseta","year":"2016","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/j.vaccine.2024.126405_bb0180","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3389\/fimmu.2019.00956","article-title":"Role of Multivalency and antigenic threshold in generating protective antibody responses","volume":"10","author":"Slifka","year":"2019","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2024.126405_bb0185","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41541-020-00223-1","article-title":"Targeting HIV Env immunogens to B cell follicles in nonhuman primates through immune complex or protein nanoparticle formulations","volume":"5","author":"Martin","year":"2020","journal-title":"NPJ Vaccines"},{"issue":"7855","key":"10.1016\/j.vaccine.2024.126405_bb0190","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/s41586-021-03365-x","article-title":"Quadrivalent influenza nanoparticle vaccines induce broad protection","volume":"592","author":"Boyoglu-Barnum","year":"2021","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.vaccine.2024.126405_bb0195","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1056\/NEJMoa2026920","article-title":"Phase 1-2 trial of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine","volume":"383","author":"Keech","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126405_bb0200","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1021\/acs.chemrev.9b00472","article-title":"Peptide-based vaccines: current Progress and future challenges","volume":"120","author":"Malonis","year":"2020","journal-title":"Chem Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2024.126405_bb0205","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/intimm\/dxp129","article-title":"Low-valency, but not monovalent, antigens trigger the B-cell antigen receptor (BCR)","volume":"22","author":"Minguet","year":"2010","journal-title":"Int Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126405_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2023.08.011","article-title":"Multivalent antigen display on nanoparticle immunogens increases B cell clonotype diversity and neutralization breadth to pneumoviruses","volume":"56","author":"Ols","year":"2023","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126405_bb0215","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136653","article-title":"Self-assembling influenza nanoparticle vaccines drive extended germinal center activity and memory B cell maturation","volume":"5","author":"Kelly","year":"2020","journal-title":"JCI Insight"},{"issue":"12","key":"10.1016\/j.vaccine.2024.126405_bb0220","doi-asserted-by":"crossref","first-page":"E690","DOI":"10.1073\/pnas.1115485109","article-title":"Peptide tag forming a rapid covalent bond to a protein, through engineering a bacterial adhesin","volume":"109","author":"Zakeri","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"31","key":"10.1016\/j.vaccine.2024.126405_bb0225","doi-asserted-by":"crossref","first-page":"11269","DOI":"10.1073\/pnas.1401291111","article-title":"Synthesis of bioactive protein hydrogels by genetically encoded SpyTag-SpyCatcher chemistry","volume":"111","author":"Sun","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7324","key":"10.1016\/j.vaccine.2024.126405_bb0230","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nature09555","article-title":"Glycoprotein organization of chikungunya virus particles revealed by X-ray crystallography","volume":"468","author":"Voss","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126405_bb0235","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1006\/jmbi.2000.4435","article-title":"X-ray structure analysis and crystallographic refinement of lumazine synthase from the hyperthermophile Aquifex aeolicus at 1.6 a resolution: determinants of thermostability revealed from structural comparisons","volume":"306","author":"Zhang","year":"2001","journal-title":"J Mol Biol"},{"issue":"6133","key":"10.1016\/j.vaccine.2024.126405_bb0240","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1234150","article-title":"Rational HIV immunogen design to target specific germline B cell receptors","volume":"340","author":"Jardine","year":"2013","journal-title":"Science (New York, NY)"},{"issue":"9","key":"10.1016\/j.vaccine.2024.126405_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009897","article-title":"Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection","volume":"17","author":"Geng","year":"2021","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126405_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.chembiol.2022.02.004","article-title":"Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo","volume":"29","author":"Georgiev","year":"2022","journal-title":"Cell Chem Biol"},{"issue":"6","key":"10.1016\/j.vaccine.2024.126405_bb0255","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010573","article-title":"A Powassan virus domain III nanoparticle immunogen elicits neutralizing and protective antibodies in mice","volume":"18","author":"Malonis","year":"2022","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126405_bb0260","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.chembiol.2022.02.004","article-title":"Resurfaced ZIKV EDIII nanoparticle immunogens elicit neutralizing and protective responses in vivo","volume":"29","author":"Georgiev","year":"2022","journal-title":"Cell chem. Biol."},{"issue":"10394","key":"10.1016\/j.vaccine.2024.126405_bb0265","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/S0140-6736(23)00641-4","article-title":"Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial","volume":"401","author":"Schneider","year":"2023","journal-title":"Lancet (London, England)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24010879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T17:42:58Z","timestamp":1741887778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24010879"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":53,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0264410X24010879"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126405","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chikungunya virus E2 B domain nanoparticle immunogen elicits homotypic neutralizing antibody in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126405","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"126405"}}